Clinical Trial Update: A Pilot Study of CelTx(TM) (Apligraf®) in the Treatment of Gingival Recession Requiring Root Coverage [Phase 1, Phase 2]

View source ↗

Summary

A pilot Phase 1/2 study of CelTx (Apligraf) for gingival recession requiring root coverage was terminated, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gingival Recession

Drugs mentioned

• Apligraf

Snippet

Sponsor: Organogenesis | Conditions: Gingival Recession | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2011-11-21